Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by greywoofon Nov 24, 2014 2:13pm

183 Views

Post# 23159009

RE:RE:Going to get busy

Hi rovaniemirover
Just wondering why your predictions are Mid-late December on Lumisort news
Are you thinking they will announce completion of the Lumisort instrument prototype and as well some initial test results

Their fiscal YE is Sept 30th ....I think TSX gives listed companies after YE around 90 days to report YE results ... Last year they reported
on Dec 30th

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading